Clinical Trial Update: SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of SAL0140 in a healthy Chinese population with the condition of uncontrolle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SAL0140

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Uncontrolled Hypertension | Phase 1 | Status: RECRUITING